ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 204 filers reported holding ARCUS BIOSCIENCES INC in Q4 2022. The put-call ratio across all filers is 2.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $490,035 | -12.6% | 27,300 | -1.1% | 0.01% | -8.3% |
| Q2 2023 | $560,556 | +26.5% | 27,600 | +13.6% | 0.01% | +9.1% |
| Q1 2023 | $443,232 | +86300.0% | 24,300 | -2.0% | 0.01% | -21.4% |
| Q4 2022 | $513 | -99.9% | 24,800 | 0.0% | 0.01% | -26.3% |
| Q3 2022 | $649,000 | +0.6% | 24,800 | +10.2% | 0.02% | +11.8% |
| Q2 2022 | $645,000 | +0.2% | 22,500 | +9.2% | 0.02% | +13.3% |
| Q1 2022 | $644,000 | – | 20,600 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |